Clinical trial
Patient Reported Outcomes in Pulmonary Arterial Hypertension
NCT01792622 is registered in ClinicalTrials.gov with Pfizer's Upjohn has merged with Mylan to form Viatris Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patient Reported Outcomes in Pulmonary Arterial Hypertension
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- July 31, 2013
- Completion date
- September 30, 2013
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.